Ofatumumab
COMB157G2402
Approved mab completed
Quick answer
Ofatumumab for Relapsing Multiple Sclerosis is a Approved program (mab) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Relapsing Multiple Sclerosis
- Phase
- Approved
- Modality
- mab
- Status
- completed